Post by
Hopeforthebest on Feb 05, 2024 3:30pm
RE:RE:RE:RE:RE:Proph. the manipulator
Proph Wrote - AEZS maintains its NASDAQ listing. CZO wants a NASDAQ listing( No no no , the only one who wants a Nasdaq listing is gagnon and once he gets if the merger goes through they will loose within a year because of gagnon's failures) and gets it. Together they will have increased news flow and an increased asset base to attract analysts and other market player. ( you honestly think that gagnon will increase news flow, hell that is the biggest lie yet proph, gagnon has diligently refused to release any data etc till necessary, usually at the end of the qrtr and only if he has too. Last year while at the helm of Czo, with all the supposed developments in the his pipedream, oops pipeline, gagnon made only 6 releases regarding propduct development, you mean to tell us that he is now going to have 7 release for the year.
Together the companies can streamline costs:
1) The TSX-V listing will be dropped.
2) They will only need one CFO, Director of Business development, etc., and only need one IR firm, etc. (yah, i have some land in Florida if you believe that garbage, gagnon made over $600,000 plus Cdn and who knows how much at Azes, he will now be paid in US dollars and it will be more than $600,000 US plus)
3) The number of members of the Board of Directors can collectively be reduced. (As I said before Carlolyn will leave with a hefty payout, freedom 55, to reward her for being puppet during the last 4 years, other officiers will also receive hefty payouts for their loyalty and silence, this is all in US $$$$$$).
4) The companies will share established pharmaceutical research and development capabilities and infrastructure to support development activities. (with all that is to be in the pipeline, R&D spending has been abismal nothing will cahnge because the pipeline is a PIPEDREAM)
Together they will have royalty revenue from AEZS's diagnostic test plus from CZO's base business. As the news release says capital from AEZS will be put towards CZO's near-term revenue generating programs to bolster near-term revenue and sustainability. Market conditions want sustainable businesses. The stated goal in the news release is a long-term sustainable company. AEZS's diagnostic deal could provide significant upfront money and milestone payments in addition to royalties. PGX could provide the same. Other assets can also be partnered from AEZS and CZO. (Azes right now is a money loosing proposition, same is Czo, nothing will change except that it will get worst under gagnon's leadership)
The company will have more a more diversified pharma portfolio composed of assets from AEZS and CZO helping to manage risk.
"The combined company will be well-capitalized to support ongoing commercial operations while strategically investing in product research and development to advance differentiated, innovative products." news release (as said above both companies are money losers and will continue to be under gagnon's leadership).
“We are thrilled with this exciting transaction to merge with Aeterna and combine two complementary companies and teams, in support of our plan to drive significant growth,” said Ronnie Miller, Chairman of Ceapro. “After careful consideration, we believe this transaction is the best way forward for Ceapro and our valued shareholders.” news release ( in the 2 years while NO SHOW RONNIE, been with Ceapro, he has made 3 announces, one to say how thrilled he is, one to deny shareholders questions and now this, Of course he is thrill, he can still work from home, not show for anything and see a massive increase as he is now being paid in US funds, who the hell wouldn't be thrilled under the gagnon ponzi scheme).
Comment by
Ciao on Feb 05, 2024 3:40pm
Surely most shareholders see through the scam merger. OATS can you see the obvious? Message me if you need convincing.